Mettler Toledo revenue
Mettler Toledo's revenue was $4.03bn in fiscal 2025, up 4.0% on the year before. Since fiscal 2009 ($1.73bn) it has grown at a compound 5.4% a year. Over the last twelve months it was $4.13bn.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,729 | 1,968 | 2,309 | 2,342 | 2,379 | 2,486 | 2,395 | 2,508 | 2,725 | 2,936 | 3,009 | 3,085 | 3,718 | 3,920 | 3,788 | 3,872 | 4,026 | 4,134 |
| Growth on the year before | — | +13.8% | +17.3% | +1.4% | +1.6% | +4.5% | −3.6% | +4.7% | +8.6% | +7.7% | +2.5% | +2.5% | +20.5% | +5.4% | −3.4% | +2.2% | +4.0% | — |
| Gross profit | 889 | 1,037 | 1,218 | 1,241 | 1,282 | 1,359 | 1,352 | 1,438 | 1,576 | 1,684 | 1,741 | 1,801 | 2,172 | 2,308 | 2,241 | 2,326 | 2,391 | 2,491 |
| Gross margin | 51.4% | 52.7% | 52.8% | 53.0% | 53.9% | 54.7% | 56.4% | 57.3% | 57.8% | 57.4% | 57.9% | 58.4% | 58.4% | 58.9% | 59.2% | 60.1% | 59.4% | 60.3% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| US Operations | $1.5B | 37.2% | ▲ 4.7% |
| Western European Operations | $896M | 22.3% | ▲ 4.4% |
| Other Operations | $789M | 19.6% | ▲ 6.9% |
| Chinese Operations | $635M | 15.8% | ▲ 1.0% |
| Swiss Operations | $211M | 5.2% | ▼ 3.5% |
| Line of business | Revenue | YoY |
|---|---|---|
| Products | $3B | ▲ 2.6% |
| Laboratoryproductsandservices | $2.2B | ▲ 2.5% |
| Industrialproductsandservices | $1.6B | ▲ 6.0% |
| Services | $1B | ▲ 8.1% |
| Retailproductsandservices | $206M | ▲ 4.9% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Mettler Toledo's 10-K filed February 6, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Mettler Toledo | $4.13bn | 6.9% | 1.5% |
| Charles River Laboratories | $4.00bn | -0.7% | -1.5% |
| Illumina, Inc. | $4.54bn | 5.8% | 0.5% |
| Waters Corporation | $4.64bn | 52.5% | 15.8% |
| Bruker Corp | $3.50bn | 1.6% | 8.8% |
| Medpace Holdings, Inc. | $2.84bn | 20.4% | 16.8% |
Compare with peers
- Charles River Laboratories revenue
- Illumina, Inc. revenue
- Waters Corporation revenue
- Bruker Corp revenue
- Medpace Holdings, Inc. revenue
Head to head: CRL vs MTDILMN vs MTDMTD vs WATBRKR vs MTD
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies